Author/Authors :
Farajzadeh, Saeedeh Department of Dermatology - School of Medicine - Leishmaniasis Research Center - Kerman University of Medical Sciences, Kerman , Sabzevari, Fatemeh Department of Pediatrics - School of Medicine - Kerman University of Medical Sciences, Kerman , Aflatoonian, Mahin Department of Dermatology - School of Medicine - Leishmaniasis Research Center - Kerman University of Medical Sciences, Kerman , Mohammadi, Saman Department of Dermatology - School of Medicine - Leishmaniasis Research Center - Kerman University of Medical Sciences, Kerman , Badakhsh, Hoda Department of Dermatology - School of Medicine - Leishmaniasis Research Center - Kerman University of Medical Sciences, Kerman , Fadaei, Fahameh Department of Dermatology - School of Medicine - Leishmaniasis Research Center - Kerman University of Medical Sciences, Kerman , Khalili, Maryam Department of Dermatology - School of Medicine - Leishmaniasis Research Center - Kerman University of Medical Sciences, Kerman
Abstract :
Kasabach-merritt syndrome is a rare life-threatening syndrome
associated with vascular tumors such as tufted angioma and
kaposiform hemangioendothelioma. For this syndrome, there
exist a few treatment modalities with variable results. For many
years, corticosteroids have been employed in the first-line therapy.
Nowadays, on the other hand, β blockers such as propranolol
have been used owing to their acceptable efficacy and fewer
side effects. In the present case report, atenolol combined with
corticosteroid was, for the first time, prescribed for the treatment
of the syndrome; a significant improvement was observed with
no concomitant side effects.
